Fly News Breaks for February 26, 2020
Feb 26, 2020 | 09:10 EDT
SVB Leerink analyst Richard Newitter raised his price target for Inspire Medical to $97 from $75 following the company's better-than-expected Q4. The analyst believes the company is entering 2020 with "growing momentum" from both commercial tailwinds picking up steam as well as Medicare reimbursement tailwinds about to start kicking-in. Newitter has an Outperform rating on the shares.
News For INSP From the Last 2 Days
There are no results for your query INSP